SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001080709-21-000028
Filing Date
2021-06-17
Accepted
2021-06-17 17:15:30
Documents
15
Period of Report
2021-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K arna-20210611.htm   iXBRL 8-K 74960
2 EX-99.1 ex991directorcompensationd.htm EX-99.1 22253
3 EX-99.2 ex992proxyexcerpt.htm EX-99.2 54244
4 EX-99.3 ex993severanceplan.htm EX-99.3 183423
  Complete submission text file 0001080709-21-000028.txt   538408

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arna-20210611.xsd EX-101.SCH 1920
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arna-20210611_lab.xml EX-101.LAB 24993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arna-20210611_pre.xml EX-101.PRE 13194
8 EXTRACTED XBRL INSTANCE DOCUMENT arna-20210611_htm.xml XML 13799
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 211025741
SIC: 2834 Pharmaceutical Preparations